CN1207909A - Oral liquid for curing cancer - Google Patents
Oral liquid for curing cancer Download PDFInfo
- Publication number
- CN1207909A CN1207909A CN97114467A CN97114467A CN1207909A CN 1207909 A CN1207909 A CN 1207909A CN 97114467 A CN97114467 A CN 97114467A CN 97114467 A CN97114467 A CN 97114467A CN 1207909 A CN1207909 A CN 1207909A
- Authority
- CN
- China
- Prior art keywords
- radix
- container
- rhizoma
- oral liquid
- inject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The oral liquor is prepared with natural Chinese medicinal materials. It can nourish Yin, promote body fluid secretion, nourish blood, promote blood circulation, disperse blood clots, eliminate swelling and resolve hard lumps and has high cure effect on stomach cancer and esophagus cancer.
Description
1, the present invention " this " oral liquid is that the multiple rare Chinese medicine of pure natural is formulated.Be mainly used in the treatment of gastric cancer, esophageal carcinoma.
2, prescription: unit (kilogram)
Radix Ginseng 4%, Radix Glehniae 6%, Radix Ophiopogonis 6%, Radix Et Rhizoma Rhei 2%, Rhizoma Zingiberis 2%, Ramulus Cinnamomi 2%, Rhizoma Coptidis 2%, Radix Salviae Miltiorrhizae 6%, Cortex Moutan 3%, the Radix Rehmanniae 6%, Radix Rehmanniae Preparata 6%, Radix Scrophulariae 6%, Radix Trichosanthis 3%, Rhizoma Dioscoreae (parching to brown) 6%, Rhizoma Polygonati Odorati 4%, broken Carapax et Plastrum Testudinis 2%, Radix Glycyrrhizae 2%, clean Semen Persicae 3%, the red Radix Paeoniae Alba each 2%, Radix Angelicae Sinensis 3%, Herba Taraxaci 3%, Herba Violae 3%, Spina Gleditsiae 2%, Radix Schisandrae Bicoloris 2%, big Fructus Jujubae (enucleation) 10%.
3, A. gets all medicines in the prescription, puts into container, injects double centner water in proportion, heats to 98 ℃, took off in 2 minutes, with medical filtration in a container.
B. get double centner water again, inject medicinal residues, heat again, took off in 5 minutes to 98 ℃, with medical filtration in a container.
C. with twice resulting medicinal liquid, be mixed in the container, heat, inject vial to 98 ℃, with 500 milliliters be standard, seal, put shady and cool dry place, the shading storage.
4, now clinically, to the treatment of gastric cancer, esophageal carcinoma, operation, chemicotherapy, its unsatisfactory curative effects of adopting more.
5, the present invention " this " oral liquid, energy YIN nourishing and the production of body fluid promoting, nourshing blood and promoting blood circulation, eliminating stagnated blood to disperse swelling, detoxicating and resolving stagnation of pathogens.
6, instructions of taking is got 500 milliliters every day, the best that is taken in small doses at short intervals on a small quantity, treat that the state of an illness is alleviated after, can suitably reduce dose.
7, the present invention " this " oral liquid has no side effect, and cures mainly gastric cancer, esophageal carcinoma, also can be used for the auxiliary treatment of other cancers.
Claims (5)
1, write out a prescription according to claim (2): Radix Ginseng 4%, Radix Glehniae 6%, Radix Ophiopogonis 6%, Radix Et Rhizoma Rhei 2%, Rhizoma Zingiberis 2%, Ramulus Cinnamomi 2%, Rhizoma Coptidis 2%, Radix Salviae Miltiorrhizae 6%, Cortex Moutan 3%, the Radix Rehmanniae 6%, Radix Rehmanniae Preparata 6%, Radix Scrophulariae 6%, Radix Trichosanthis 3%, Rhizoma Dioscoreae (parching to brown) 6%, Rhizoma Polygonati Odorati 4%, broken Carapax et Plastrum Testudinis 2%, Radix Glycyrrhizae 2%, clean Semen Persicae 3%, the red Radix Paeoniae Alba each 2%, Radix Angelicae Sinensis 3%, Herba Taraxaci 3%, Herba Violae 3%, Spina Gleditsiae 2%, Radix Schisandrae Bicoloris 2%, big Fructus Jujubae (enucleation) 10%.
2, get all medicines in the prescription according to claim (3) A, put into container, inject double centner water in proportion, heat, took off in 2 minutes to 98 ℃, with medical filtration in a container.B. get double centner water again, inject medicinal residues, heat again, took off in 5 minutes to 98 ℃, with medical filtration in a container.C. with twice resulting medicinal liquid, be mixed in the container, heat, inject vial to 98 ℃, with 500 milliliters be standard, seal.Put shady and cool dry place, the shading storage.
3, according to claim (5) the present invention " this " oral liquid, energy YIN nourishing and the production of body fluid promoting, nourshing blood and promoting blood circulation, eliminating stagnated blood to disperse swelling, detoxicating and resolving stagnation of pathogens.
4, according to claim (6) instructions of taking, get 500 milliliters every day, the best that is taken in small doses at short intervals on a small quantity, treat that the state of an illness is alleviated after, can suitably reduce dose.
5, according to claim (7) the present invention " this " oral liquid, have no side effect, cure mainly gastric cancer, esophageal carcinoma, also can be used for the auxiliary treatment of other cancers.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97114467A CN1062176C (en) | 1997-08-13 | 1997-08-13 | Oral liquid for curing cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97114467A CN1062176C (en) | 1997-08-13 | 1997-08-13 | Oral liquid for curing cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1207909A true CN1207909A (en) | 1999-02-17 |
CN1062176C CN1062176C (en) | 2001-02-21 |
Family
ID=5172971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN97114467A Expired - Fee Related CN1062176C (en) | 1997-08-13 | 1997-08-13 | Oral liquid for curing cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1062176C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1100555C (en) * | 1999-07-20 | 2003-02-05 | 康法林 | Medicine for treating cancer |
CN1813967B (en) * | 2005-02-02 | 2010-07-14 | 边仪广 | Chinese medicine remedy for treating cancer of alimentany tract |
CN103028059A (en) * | 2012-12-23 | 2013-04-10 | 丁常燕 | Traditional Chinese medicine composition for treating cholangiocarcinoma |
CN103893731A (en) * | 2014-04-15 | 2014-07-02 | 齐春发 | Traditional Chinese medicine for treating esophagus cancer, gastric cancer, liver cancer and brain tumor and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1049339C (en) * | 1993-05-10 | 2000-02-16 | 李文升 | Chinese drug tumour removing powder and its preparation |
CN1127652A (en) * | 1995-08-28 | 1996-07-31 | 陈尔东 | Oral liquid for restoration of cancer |
-
1997
- 1997-08-13 CN CN97114467A patent/CN1062176C/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1100555C (en) * | 1999-07-20 | 2003-02-05 | 康法林 | Medicine for treating cancer |
CN1813967B (en) * | 2005-02-02 | 2010-07-14 | 边仪广 | Chinese medicine remedy for treating cancer of alimentany tract |
CN103028059A (en) * | 2012-12-23 | 2013-04-10 | 丁常燕 | Traditional Chinese medicine composition for treating cholangiocarcinoma |
CN103893731A (en) * | 2014-04-15 | 2014-07-02 | 齐春发 | Traditional Chinese medicine for treating esophagus cancer, gastric cancer, liver cancer and brain tumor and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1062176C (en) | 2001-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101703730B (en) | Health care wine made of ginseng and the like | |
CN100496586C (en) | Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
CN101642535B (en) | Medicinal composition for treating gout | |
CN1103589A (en) | Plaster for treating respiratory system diseases | |
CN100548349C (en) | Wine capable of prolonging life | |
CN1435215A (en) | Zaizao Pill for treating woman diseases | |
CN102205059A (en) | Chinese herbal medicine composition for treating liver cancer, stomach cancer, lung cancer and leukemia and preparation method thereof | |
CN1049827C (en) | Anti-cancer powder | |
CN1062176C (en) | Oral liquid for curing cancer | |
CN1056064C (en) | Medicine for curing liver cancer and its making method | |
CN1114206A (en) | Plaster for curing dysmenorrhea | |
CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
CN104189764A (en) | Traditional Chinese medicinal preparation for treating intervention postoperative fever | |
CN1058911A (en) | The compound method of capsule for curing tumour | |
CN1063066C (en) | Chinese medicine for treatment of gout | |
CN105998645A (en) | Traditional Chinese medicine composition for treating leukotrichia and lipsotrichia | |
CN1274348C (en) | Production process of hair restorer bolus | |
CN1151313A (en) | Method for prepn. of drug for treatment of colitis, peptic ulcer and haemorrhage | |
CN101130020A (en) | Powder medicine of ginseng and beard for clearing lung-heat | |
CN1078476C (en) | Gastric cancer treating Chinese medicine preparation | |
CN105232826A (en) | Traditional Chinese medicinal composition for treating diarrhea, preparation method and medicine of traditional Chinese medicinal composition | |
CN1049599C (en) | Medicine for treatment of thromboangiitis obliterans | |
CN1115162C (en) | Pure traditional Chinese medicine for treating hyperosteogeny and preparation process thereof | |
CN101708322B (en) | Rheumatism-treating medicinal liquor | |
CN104027535A (en) | Chinese herbal compound composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |